These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 2769966
21. Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. Hoffman R, Zanjani ED, Lutton JD, Zalusky R, Wasserman LR. N Engl J Med; 1977 Jan 06; 296(1):10-3. PubMed ID: 830263 [Abstract] [Full Text] [Related]
22. Effects of fibroblasts on the growth of erythroid progenitor cells in vitro. Ghio R, Bianchi G, Löwenberg B, Dicke KA, Ajmar F. Exp Hematol; 1977 Sep 06; 5(5):341-7. PubMed ID: 902701 [Abstract] [Full Text] [Related]
23. Responsiveness of bone marrow erythroid progenitors (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in multiple myeloma. Aoki I, Nishijima K, Homori M, Nakahara K, Higashi K, Ishikawa K. Br J Haematol; 1992 Aug 06; 81(4):463-9. PubMed ID: 1390230 [Abstract] [Full Text] [Related]
24. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Malgor LA, Valsecia M, Vergés E, De Markowsky EE. Acta Physiol Pharmacol Ther Latinoam; 1998 Aug 06; 48(2):99-105. PubMed ID: 9695882 [Abstract] [Full Text] [Related]
25. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure. Glaser M. Med Sci Monit; 2006 Mar 06; 12(3):CR113-7. PubMed ID: 16501421 [Abstract] [Full Text] [Related]
26. The in vivo effects of recombinant human erythropoietin on cisdiamminodichloroplatinum-induced anemia in golden Syrian hamsters. Gebbia V, Palmeri S, Valenza R, Rausa L, Citarrella P. In Vivo; 1991 Mar 06; 5(2):149-52. PubMed ID: 1768784 [Abstract] [Full Text] [Related]
27. Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia. Wodnar-Filipowicz A, Chklovskaia E, Manz CY, Lyman SD, Nissen C. Exp Hematol; 1997 Jul 06; 25(7):573-81. PubMed ID: 9216732 [Abstract] [Full Text] [Related]
28. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM, Gulati SC. Stem Cells; 1993 Sep 06; 11(5):435-44. PubMed ID: 7694721 [Abstract] [Full Text] [Related]
29. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Roodman GD, Bird A, Hutzler D, Montgomery W. Exp Hematol; 1987 Oct 06; 15(9):928-35. PubMed ID: 2820776 [Abstract] [Full Text] [Related]
30. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3. Gibson FM, Scopes J, Daly S, Ball SE, Gordon-Smith EC. Exp Hematol; 1994 Mar 06; 22(3):302-12. PubMed ID: 8112428 [Abstract] [Full Text] [Related]
31. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM. Exp Hematol; 1993 Nov 06; 21(12):1583-90. PubMed ID: 7691640 [Abstract] [Full Text] [Related]
32. Abnormalities of hematopoietic progenitor cells in patients with aplastic anemia after hematologic recovery. Issaragrisil S, Piankijagum A, Tang-Naitrisorana Y. J Med Assoc Thai; 1989 Nov 06; 72(11):643-8. PubMed ID: 2635209 [Abstract] [Full Text] [Related]
33. Regeneration of erythroid progenitor cells in polycythemic mice treated with cyclophosphamide. Biljanović-Paunović L, Milenković P, Kapa D, Pavlović-Kentera V. Exp Hematol; 1985 Jan 06; 13(1):67-73. PubMed ID: 3972018 [Abstract] [Full Text] [Related]
34. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec 06; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
35. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures. Lu L, Welte K, Gabrilove JL, Hangoc G, Bruno E, Hoffman R, Broxmeyer HE. Cancer Res; 1986 Sep 06; 46(9):4357-61. PubMed ID: 3089590 [Abstract] [Full Text] [Related]
36. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells. Taniguchi S, Dai CH, Krantz SB. Exp Hematol; 1997 Mar 06; 25(3):193-8. PubMed ID: 9091293 [Abstract] [Full Text] [Related]
37. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment. Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M. Exp Hematol; 1993 Apr 06; 21(4):496-501. PubMed ID: 8462658 [Abstract] [Full Text] [Related]
40. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin. Sieff CA, Emerson SG, Mufson A, Gesner TG, Nathan DG. J Clin Invest; 1986 Jan 06; 77(1):74-81. PubMed ID: 3511093 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]